Literature DB >> 8006921

Low-Km aldehyde dehydrogenase deficiency does not influence the elevation of blood pressure by alcohol.

A Okayama1, H Ueshima, M Yamakawa, Y Kita.   

Abstract

Increased alcohol consumption causes hypertension and leads to higher death rates by hemorrhagic strokes. About half of the Japanese population have inactive low Km aldehyde dehydrogenase (ALDH2), which metabolizes acetaldehyde to acetic acid at very low concentrations, leading to severe pharmacological effects of aldehyde when drinking alcohol. We determined persons with inactive ALDH2 using a ethanol patch test. All male workers (n + 163), aged from 21 to 62 years in one factory in Japan took part. They were divided into two groups by alcohol consumption (nondrinkers, light drinkers of < 32 ml/l ethanol per day and moderate to heavy drinkers of > or = 32 ml ethanol per day). The prevalence of persons with inactive ALDH2 was 52.1%. The prevalence of moderate to heavy drinkers among persons with inactive ALDH2 was significantly lower than that among those with active ALDH2 (23% and 41%, respectively: P < 0.05). No significant differences of BP were observed between ALDH2 inactive and active groups at the same consumption of alcohol. This study showed a significant relationship between categories of alcohol use and SBP and DBP (P < 0.05, respectively) controlled for age and body mass index. The mechanism by which alcohol use elevates BP is unlikely to be related to the inactive ALDH2. However, inactive ALDH2 may act as a protective factor against hypertension by reducing alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006921

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

1.  Associations between aldehyde dehydrogenase 2 (ALDH2) genetic polymorphisms, drinking status, and hypertension risk in Japanese adult male workers: a case-control study.

Authors:  Mitsunori Ota; Aya Hisada; Xi Lu; Chihiro Nakashita; Shouta Masuda; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2015-08-30       Impact factor: 3.674

2.  ALDH2 and CYP2E1 genotypes, urinary acetaldehyde excretion and the health consequences in moderate alcohol consumers.

Authors:  Yuichi Yamada; Tsunehiko Imai; Masao Ishizaki; Ryumon Honda
Journal:  J Hum Genet       Date:  2005-12-20       Impact factor: 3.172

3.  Does the flushing response modify the relationship between alcohol intake and hypertension in the Japanese population? NIPPON DATA2010.

Authors:  Mana Kogure; Naho Tsuchiya; Atsushi Hozawa; Naoki Nakaya; Tomohiro Nakamura; Naomi Miyamatsu; Hideo Tanaka; Ichiro Wakabayashi; Aya Higashiyama; Nagako Okuda; Naoyuki Takashima; Akira Fujiyoshi; Aya Kadota; Takayoshi Ohkubo; Tomonori Okamura; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  Hypertens Res       Date:  2016-05-12       Impact factor: 3.872

4.  Blood pressure, levels of serum lipids, liver enzymes and blood glucose by aldehyde dehydrogenase 2 and drinking habit in Japanese men.

Authors:  Sayuri Nakamura; Yoshinori Ito; Koji Suzuki; Shuji Hashimoto
Journal:  Environ Health Prev Med       Date:  2006-03       Impact factor: 3.674

5.  The association of alcohol and alcohol metabolizing gene variants with diabetes and coronary heart disease risk factors in a white population.

Authors:  Lise Lotte N Husemoen; Torben Jørgensen; Knut Borch-Johnsen; Torben Hansen; Oluf Pedersen; Allan Linneberg
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

Review 6.  Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach.

Authors:  Lina Chen; George Davey Smith; Roger M Harbord; Sarah J Lewis
Journal:  PLoS Med       Date:  2008-03-04       Impact factor: 11.069

7.  Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study.

Authors:  Wei Sen Zhang; Lin Xu; Catherine Mary Schooling; Chao Qiang Jiang; Kar Keung Cheng; Bin Liu; Tai Hing Lam
Journal:  Hypertens Res       Date:  2013-04-25       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.